Greenstone Biosciences的动态

Missed SLAS earlier this month? Make sure to download our poster! From the 3rd to 7th February, we were in Boston for the Society for Laboratory Automation and Screening (SLAS) International Conference, discussing our work with human iPSC technology for research and drug discovery. Alongside discussions on quality iPSC manufacturing, functional QC and in vitro models, we presented a poster titled "Differentiation of multiple iPSC lines to different cell types to enable cohort analysis in neurodegeneration: challenges and learnings". Listen to our Project Manager, Sian Humphreys presenting the key findings in the poster: https://hubs.la/Q02m28G90 Click here to download the poster: https://hubs.la/Q02m29CX0 #iPSCs #SLAS #biotech #StemCells #DrugDiscovery

View our panel discussion on-demand to hear about the latest developments in advanced cell culture models and lipid technologies for lipid-based mRNA delivery systems. Our expert panel shared insights on use of complex lipids and creation of 3D models that more accurately replicate the in vivo environment. #3DCellCulture #drugdiscovery #mRNA

“How recent technological advancements such as spatial biology, single cell genomics, and complex in vitro models are revolutionizing the way drugs are developed." Upcoming Keynote Lecture David Walt, PhD, Scientific Founder of Illumina and Professor of Pathology at @Harvard Medical School.? ? I've had the pleasure to visit with David Walt in Boston and welcome him Toulouse when I was in the field of Electronic Noses (Pattern Recognition and Chemical sensors). Our paths have not crossed directly again. I recently realized we (Primetech Corporation) distributes ground breaking Spatial Biology Solutions from Vizgen in Japan where he is one of the founders. His Keynote Lecture is in Drug Discovery Day on April 3rd with Endpoints News. In the meantime, I recommend you check out last year’s Drug Discovery Day which I missed until yesterday. Fortunately, available on demand and still very relevant today. "The heat is on to find new ways to advance preclinical drug research" with?David Grainger, Centessa Pharmaceuticals; Lorna Ewart, Emulate, Inc.; John Connolly, Parker Institute for Cancer Immunotherapy; John Carroll, Endpoints News. #preclinical #drugdiscovery #drugdevelopment #spatialbiology #singlecellgenomics #nams (by FDA)

?? Will you be at #BioCenturyGrandRounds in #Nashville this week? Join Marinna Madrid, PhD, Co-Founder & Chief Product Officer at Cellino, for a panel discussion with Erin Kimbrel of Astellas Pharma, Samuel Lynch of Lynch Regenerative Medicine, and Krishnendu Roy of Vanderbilt University on "The Regenerative Moment: Are iPSCs Poised to Reshape the Cell Therapy Toolbox?" Stephanie Oestreich of Multiple Myeloma Research Foundation - MMRF will lead the session on September 10 from 2:10 PM to 2:50 PM EDT, exploring: ?? Fidelity of reprogramming and what can be gleaned about it in the age of single-cell transcriptomics ?? Durability of cells and their longevity in the current technological landscape ?? Best practices for manipulating and scaling cells without compromising their benefits Our team can’t wait to discuss how iPSCs compare with other regenerative approaches, including protein therapeutics and traditional modalities. We’re excited to see you soon! ?? Download the conference brochure: https://bit.ly/3Yl18Df ?? Register here: https://bit.ly/3yvgGcV #Biotech #ResearchandDevelopment #Innovation #Biomanufacturing #Autologous #AI #MachineLearning #PersonalizedMedicine #RegenMed #YourCellsYourCure #CellinoBio

Transforming Drug Discovery with Spatial Biology: A Virtual Event You Can’t Miss! Did you know over 90% of drugs fail in development, costing time, resources, and potential breakthroughs for patients? Spatial biology is changing this paradigm, providing unprecedented insights that could reshape therapeutic development and precision medicine. Join us for an impactful virtual event featuring top experts who are advancing spatial biology from discovery to clinical applications. Discover how innovative tools and methods are unlocking complex biological systems, supporting precision biomarkers, and paving the way for breakthroughs in immuno-oncology and companion diagnostics. Key sessions include: 1. Advancing Spatial Biology Discoveries to the Clinic by Mark Landers. 2. Multiplex Immunohistochemistry Assay for Immune Cell Identification in Non-Human Primate Ocular Tissues by Rong (Ronnie) Nie from Abbvie. 3. Application of Multiplex Immunofluorescence Assays for Immuno-Oncology Drug Development and Potential for Companion Diagnostics by Chung-Wein Lee from Genmab. 4. Roundtable Discussion led by our very own Cameron Smurthwaite MSc, MBA. Don’t miss this opportunity to explore how spatial biology is driving a new era in drug discovery and clinical care. Register now: https://lnkd.in/ebJHWbVb #TheSpatialBiologyCompany #PhenoTalks #PhenoCycler #PhenoImager #DrugDiscovery #NewFrontiers

We found this via The Scientist Explore the clinical potential of #NKcell therapies and learn how scientists scale up large-scale #cellculture methods for therapeutic purposes in this webinar by Thermo Fisher Scientific. #livecellshipment #application

Are you a researcher looking to accelerate cell line development, drug discovery, and streamline image analysis??SYNENTEC, understand your challenges. SYNENTEC?high-throughput cell imaging systems can help you shorten cell line development timelines and increase the efficiency of drug candidate screening. Additionally, AI-STUDIO+ and AI-SERVER empower you to overcome limitations of generic image analysis software. Train custom AI models for your specific needs, whether it's identifying rare cell types or quantifying protein expression. Reduce analysis time by up to 50% and gain deeper insights for more informed decisions. Ready to revolutionize your research? Schedule a free consultation to discuss how SYNENTEC's solutions can meet your specific needs. #CellLineDevelopment?#CancerResearch #DrugDiscovery? #StemCellResearch ?#Immunology https://lnkd.in/emutRAE9

Happy International Clinical Trials Day! Today, we honour clinical trial professionals and the inspirational volunteers who participate in clinical research. Their dedication is vital to advancing medical science and improving patient outcomes. The future of human health will be defined by technologies that accelerate the world's access to more effective medicines. bit.bio is democratising access to human cells and cell therapies by leveraging a new paradigm in biology – deterministic cell programming. Via both our ioCells research and drug discovery product portfolio and our txCells?-based cell therapy pipeline, bit.bio is working to improve the therapeutic development process and transform human health. Watch our video to see how we aim to develop novel therapeutics. Read more about Clinical Trials Day: https://hubs.ly/Q02xN7-x0 https://hubs.ly/Q02xMWJL0 https://hubs.ly/Q02xMXcx0 #ClinicalTrialsDay #CTD2024 #InternationalClinicalTrialsDay #ICTD2024 #Health #Innovation

?? Exciting News Alert! ?? I'm thrilled to announce the publication of our latest research paper titled "Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin" in the International Journal of Nanomedicine! ?? In this study, we delved into the intricate mechanisms behind the brain targeting of doxorubicin-loaded polybutyl cyanoacrylate (PBCA) nanoparticles, shedding light on their interactions with the blood-brain barrier (BBB) - a crucial obstacle in brain cancer treatment. ???? Our findings revealed a groundbreaking discovery: while Doxil? behaved as expected, accumulating in the brain through extravasation in tumor tissue, surfactant-coated PBCA nanoparticles utilized a unique mechanism termed "cell hitchhiking." This resulted in an astounding more than 1000-fold increase in brain permeation rate compared to Doxil?! ?? I extend my heartfelt gratitude to Matthias G. Wacker, my former supervisor, and all my colleagues in his lab (https://lnkd.in/guCBgxTW) and NUS for their invaluable support and contribution to this achievement. None of this would have been possible without your guidance and collaboration! ?? This research opens new avenues for enhancing drug delivery to the brain, offering hope for more effective treatments for brain cancer patients. ?? Read the full paper here: https://lnkd.in/gbDqK7Tc #Research #Nanomedicine #DrugDelivery #BrainCancerTreatment #Collaboration #Wackerlab #NUS

?? Dive into the Future of Biomedical Research with Our Latest Global Live Cell Imaging Market Report! ???? Live cell imaging is a revolutionary technique that allows scientists to observe cellular processes in real time, providing invaluable insights into cellular functions and interactions. This technology is transforming fields such as cancer research, drug discovery, and regenerative medicine by enabling researchers to study living cells in their natural environment. The global market for live cell imaging is set for impressive growth. It is projected to expand from $2.9 billion in 2024 to $4.3 billion by 2029, with a CAGR of 8.4% during the forecast period. ???? Stay ahead of the curve and explore the key trends, innovations, and market drivers fueling this growth. Whether in biotech, pharmaceuticals, or academic research, this report provides the insights you need to capitalize on this expanding market. ?? Read more on our Report! https://bit.ly/3XBP13Z #LiveCellImaging #BiomedicalResearch #CellBiology #BiotechInnovation #MarketTrends #HealthcareTech #ResearchAndDevelopment #GlobalMarketInsights #CAGR #Biotechnology #DrugDiscovery